Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285992422> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4285992422 endingPage "B21" @default.
- W4285992422 startingPage "B21" @default.
- W4285992422 abstract "Psoriasis is a chronic inflammatory skin disease. Dysregulation of the epidermal barrier in psoriasis has been demonstrated and epigenetic modifications have been found to be associated with psoriasis. TET2 has dioxygenase activity and oxidizes 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), and is a key regulator of DNA demethylation. There is a lack of studies on the effect of TET2 on the epidermal barrier in psoriasis. We observed reduced expression of TET2 and 5hmc in the lesions of psoriasis patients. In imiquimod psoriatic dermatitis mice, we obtained similar results by immunohistochemistry. We constructed epidermal TET2 conditional knockout mice (TET2CKO). In the imiquimod psoriasis dermatitis model, TET2CKO mice presented more severe erythema, scaling and skin thickness. The TEWL assay was performed on imiquimod-treated mice and was elevated in the TET2CKO group. This indicates that epidermal TET2 deficiency exacerbates psoriatic dermatitis in mice. We next examined the expression of K14, K10, filaggrin, involucrin, which represent proliferation and differentiation, TET2CKO mice showed K14, involucrin increased and K10, filaggrin decreased. TET2 absence may accelerate the proliferation and inhibit differentiation of keratinocytes. We subsequently observed that intercellular linker molecules Claudin-1 and E-cadherin were both downregulated in TET2CKO mice. In conclusion, deletion of epidermal TET2 is involved in dysregulation of the skin barrier. By RNAseq, we found that FLG mRNA is reduced after TET2 knockdown. Deficiency of filaggrin encoded by the FLG gene, leads to impaired epidermal barrier. Filaggrin expression reduced but mutations in the FLG gene have been reported to be rarely observed in psoriasis, therefore we suppose that FLG gene expression might be regulated by TET2, which is an alternative mechanism for barrier dysregulation in non-mutant FLG patients." @default.
- W4285992422 created "2022-07-21" @default.
- W4285992422 creator A5001555131 @default.
- W4285992422 creator A5030383659 @default.
- W4285992422 creator A5084593880 @default.
- W4285992422 date "2022-08-01" @default.
- W4285992422 modified "2023-09-28" @default.
- W4285992422 title "LB964 TET2 participates in the dysregulation of skin barrier in psoriasis" @default.
- W4285992422 doi "https://doi.org/10.1016/j.jid.2022.05.985" @default.
- W4285992422 hasPublicationYear "2022" @default.
- W4285992422 type Work @default.
- W4285992422 citedByCount "0" @default.
- W4285992422 crossrefType "journal-article" @default.
- W4285992422 hasAuthorship W4285992422A5001555131 @default.
- W4285992422 hasAuthorship W4285992422A5030383659 @default.
- W4285992422 hasAuthorship W4285992422A5084593880 @default.
- W4285992422 hasBestOaLocation W42859924221 @default.
- W4285992422 hasConcept C105702510 @default.
- W4285992422 hasConcept C190684412 @default.
- W4285992422 hasConcept C203014093 @default.
- W4285992422 hasConcept C2776008674 @default.
- W4285992422 hasConcept C2776088058 @default.
- W4285992422 hasConcept C2776458125 @default.
- W4285992422 hasConcept C2777074287 @default.
- W4285992422 hasConcept C2777577635 @default.
- W4285992422 hasConcept C2778329239 @default.
- W4285992422 hasConcept C2779112978 @default.
- W4285992422 hasConcept C2780564577 @default.
- W4285992422 hasConcept C502942594 @default.
- W4285992422 hasConcept C54355233 @default.
- W4285992422 hasConcept C71924100 @default.
- W4285992422 hasConcept C81885089 @default.
- W4285992422 hasConcept C86803240 @default.
- W4285992422 hasConceptScore W4285992422C105702510 @default.
- W4285992422 hasConceptScore W4285992422C190684412 @default.
- W4285992422 hasConceptScore W4285992422C203014093 @default.
- W4285992422 hasConceptScore W4285992422C2776008674 @default.
- W4285992422 hasConceptScore W4285992422C2776088058 @default.
- W4285992422 hasConceptScore W4285992422C2776458125 @default.
- W4285992422 hasConceptScore W4285992422C2777074287 @default.
- W4285992422 hasConceptScore W4285992422C2777577635 @default.
- W4285992422 hasConceptScore W4285992422C2778329239 @default.
- W4285992422 hasConceptScore W4285992422C2779112978 @default.
- W4285992422 hasConceptScore W4285992422C2780564577 @default.
- W4285992422 hasConceptScore W4285992422C502942594 @default.
- W4285992422 hasConceptScore W4285992422C54355233 @default.
- W4285992422 hasConceptScore W4285992422C71924100 @default.
- W4285992422 hasConceptScore W4285992422C81885089 @default.
- W4285992422 hasConceptScore W4285992422C86803240 @default.
- W4285992422 hasIssue "8" @default.
- W4285992422 hasLocation W42859924221 @default.
- W4285992422 hasOpenAccess W4285992422 @default.
- W4285992422 hasPrimaryLocation W42859924221 @default.
- W4285992422 hasRelatedWork W2022368774 @default.
- W4285992422 hasRelatedWork W2029653522 @default.
- W4285992422 hasRelatedWork W2036560885 @default.
- W4285992422 hasRelatedWork W2093396823 @default.
- W4285992422 hasRelatedWork W2112448498 @default.
- W4285992422 hasRelatedWork W2257096610 @default.
- W4285992422 hasRelatedWork W3031520310 @default.
- W4285992422 hasRelatedWork W4213164200 @default.
- W4285992422 hasRelatedWork W4237548235 @default.
- W4285992422 hasRelatedWork W4285992422 @default.
- W4285992422 hasVolume "142" @default.
- W4285992422 isParatext "false" @default.
- W4285992422 isRetracted "false" @default.
- W4285992422 workType "article" @default.